The following information should be read in conjunction with our financial
statements and accompanying notes included in this Annual Report on Form 10-K.
Overview
We own and operate CNP Operating, a leading CBD manufacturer vertically
integrated with a 360 degree approach to the processing of high quality CBD
products designed for growers, pharmaceutical, wellness providers, and
retailers' needs, and a cannabis industry focused sponsored content and
marketing business, or the CFN Business. Our ongoing operations currently
consist primarily of CNP Operating and the CFN Business and we will continue to
pursue strategic transactions and opportunities. We are currently in the process
of launching an e-commerce network focused on the sale of general wellness CBD
products.
CNP Operating provides toll processing services which includes extraction,
distillation, remediation, isolation and chromatography. CNP Operating has a
professional, organized and dedicated team with 30 years of combined experience.
CNP Operating's state of the art facility has 30,000 square feet filled with
proprietary technology distillation equipment, in house lab testing,
distribution warehouse and white labelling product formulation and design.
The CFN Business generates revenue through sponsored content, including
articles, press releases, videos, podcasts, advertisements and other media,
email advertisements and other marketing campaigns run on behalf of public and
private companies in the cannabis industry, helping them reach accredited,
retail and institutional investors. Most revenue is generated through contracts
involving a monthly cash payment.
The CFN Business' primary expenses come from advertising on platforms like
Twitter and Facebook and from employee salaries and contractor fees. The CFN
Business' content is primarily produced by a team of freelance writers and video
content is produced through various vendors. The CFN Business also incurs
hosting and development costs associated with maintaining and improving its
website, web applications, and mobile applications. The CFN Business operates
several media platforms, including CannabisFN.com, the CannabisFN iOS app, the
CFN Media YouTube channel, the CFN Media podcast, and other venues. These
properties are designed to educate and inform investors interested in the
cannabis industry, as well as provide a platform for the clients of the CFN
Business to reach investors. The CFN Business distributes content across
numerous online platforms, including the CannabisFN.com website, press releases,
financial news syndicates, search engines, YouTube, iTunes, Twitter, Instagram,
Facebook, LinkedIn, and others.
The CFN Business targets the legal cannabis industry. According to Grand View
Research, the global cannabis industry is expected to reach $146.4 billion by
2025, driven by the legalization of medical and adult-use cannabis across a
growing number of jurisdictions. According to the Marijuana Index, there are
approximately 400 public companies involved in the cannabis industry, which
represents the primary target market of the CFN Business. The CFN Business'
services are designed to help private companies prepare to go public and public
companies grow their shareholder base through sponsored content and marketing
outreach. The success of the CFN Business depends on the legal status of
cannabis, investor demand for cannabis investments, and numerous other external
factors.
The CFN Business competes with other public relations firms for clients, as well
as online publishers for investors. Public relations competition includes
investor awareness firms like Stockhouse Publishing, Catalyst Xchange,
Stonebridge Partners and Midan Ventures. Online publisher competition includes
firms like New Cannabis Ventures, Leafly and High Times. The CFN Business is
regulated by rules established by the SEC, FINRA, and certain federal and state
cannabis regulations.
--------------------------------------------------------------------------------
18
--------------------------------------------------------------------------------
Results of Operations
The following are the results of our operations for the year ended December 31,
2022 as compared to the year ended December 31, 2021:
Year Ended
December 31,
2022 2021 Change
Net revenues $4,317,490 $3,157,783 $1,159,707
Cost of revenue 6,512,109 3,539,636 2,972,473
Gross profit (loss) (2,194,619) (381,853) (1,812,766)
Operating expenses:
Impairment expense 3,615,961 9,355,657 (5,739,696)
Selling, general and administrative 2,641,842 2,691,258 (49,416)
Total operating expenses 6,257,802 12,046,915 (5,789,113)
Loss from operations (8,452,422) (12,428,768) 3,976,346
Other income (expense):
Loss on conversion of debt (563,220) - (563,220)
Unrealized loss on marketable
securities (46,516) (45,658) (858)
Impairment of investments (200,000) - (200,000)
Loss on extinguishment of debt - (172,500) 172,500
SBA PPP loan forgiveness - 526,000 (526,000)
Interest expense (694,380) (93,170) (601,210)
Interest income 113 10,011 (9,898)
Other income 34,206 - 34,206
Total other income (expense),
net (1,469,797) 224,683 (1,694,480)
Provision for income taxes - - -
Net loss $(9,922,219) $(12,204,085) $2,281,866
Net Revenues
The Company's revenues are generated from the sale of promotional service
packages to customers ranging from 3 to 6 months. The Company offers different
packages tailored to the type and stage of the potential customer, such as
public companies looking to increase their shareholder base, as well as private
companies potentially looking to go public and attract capital and publicity.
During the year ended December 31, 2022, the Company realized $366,000 of
campaign revenue compared to $684,000 for the same period in the prior year.
The Company's subsidiary CNP Operating generated revenue of $3.9 and $3.0
million, respectively from the sale of products produced from hemp material and
manufactured into CBD distillate for the years ended December 31, 2022 and 2021.
Our revenue for 2022 and 2021 also included $96,706 and $58,629, respectively,
relating to sales of product from our e-commerce network focused on the sale of
general wellness CBD products for the years ended December 31, 2022 and 2021.
Costs of Revenue
The costs of revenue consist primarily of labor, fees paid for production of
content for clients and the costs of placement of the content on various
platforms. In 2022, the contracts required more production services and related
labor than the contracts in 2021. As a result, the cost of revenue in 2022 was
higher as a percentage of the revenue recognized during the year.
--------------------------------------------------------------------------------
19
--------------------------------------------------------------------------------
The Company's cost of revenue for the year ended December 31, 2022 were higher
than those in the corresponding year in 2021 due largely to the acquisition of
CNP Operating in August 2021. CNP cost of revenue was approximately $6.5 million
in 2022, which primarily represents the cost of hemp material, manufacturing
material such as solvent, fuel and equipment depreciation.
Operating Expenses
The Company's operating expenses for the year ended December 31, 2022 were lower
than those in the corresponding year in 2021 due to cost-cutting measures and
the decreased operations of CNP during 2022. In 2022, the Company recorded $3.6
million in impairment of property and equipment and right of use assets, and in
2021 the Company wrote off goodwill of $9.3 million.
Other Income (Expense)
Other income (expense) was ($1.3) million in 2022 compared to $0.2 million in
2021. This was due to a loss on conversion of debt of $563,220, impairment of
investments of $200,000 and interest expense of $694,380 in 2022.
Liquidity and Capital Resources
As of December 31, 2022, we had $12,474 in unrestricted cash and $4,066,587 in
notes payable.
The Company had a working capital deficit of $8,802,958 and an accumulated
deficit of $58,996,099 as of December 31, 2022. The Company also had a net loss
of $9,922,219 for the year ended December 31, 2022.
Management's plan to continue as a going concern includes raising capital in the
form of debt or equity, growing its existing business acquired under the
Emerging Growth Agreement, managing and reducing operating and overhead costs
and continuing to pursue strategic transactions and opportunities including
launching an e-commerce network focused on the sale of general wellness CBD,
products.
These matters, among others, raise substantial doubt about the ability of the
Company to continue as a going concern. These financial statements do not
include any adjustments to the amounts and classification of assets and
liabilities that may be necessary should the Company be unable to continue as a
going concern.
The following is a summary of our cash flows from operating, investing and
financing activities for the years ended December 31, 2022 and 2021:
Year Ended
December 31,
2022 2021
Cash flows used in operating activities $(1,418,850) $(344,214)
Net cash used in (provided by) investing activities $(339,655) $22,885
Cash flows provided by financing activities
$1,601,078 $331,243
Net cash used in operating activities was $1,418,850 during the year ended
December 31, 2022, compared to $344,214 during the same period in 2021. The
increase in cash used in operating activities was primarily driven by a lower
net loss in 2022.
Net cash used in investing activities $339,665 during the year ended December
31, 2022, compared with cash provided in investing activities of $22,885 during
the same period in 2021. In 2022, cash used in investing activities was due to
purchases of property and equipment. In 2021, net cash provided by investing
activities was due to CNP cash acquired. In 2022, net cash provided by investing
activities was due to purchase of property and equipment.
Net cash provided by financing activities was $1,601,078 for the year ended
December 31, 2022, was the result of proceeds from net advances from related
parties $7,995, the sale of common stock for $410,000, promissory notes of
$1,233,000 and payment of notes payable of $49,917. In 2021, net cash provided
by financing activities was $331,243
--------------------------------------------------------------------------------
20
--------------------------------------------------------------------------------
for the year ended December 31, 2021 was the result of proceeds from a second
PPP loan of $411,894, the sale of common stock for $10,000 and the exercise of
$50,000 of warrants.
Description of Indebtedness
On September 10, 2019, the Company entered into a promissory note payable
whereby the Company borrowed $500,000 bearing interest at 8% per annum. Interest
on the note is payable quarterly on the first business day of December, March,
June and September commencing December 1, 2019. In May 2021, the Company and the
holder of the promissory note reached an agreement to extend the maturity date
of the note from September 30, 2022 to September 30, 2024. In connection with
the extension, the Company issued 160,000 shares of its common stock to the
noteholder in lieu of $40,000 of interest accrued and accruing on the promissory
note through December 31, 2022.
In connection with the promissory note on September 10, 2019, the Company issued
warrants to purchase 33,333 shares of the Company's common stock at an exercise
price of $1.50 per share. The warrants were exercised on June 30, 2021 and the
Company received $50,000. The note was discounted by $17,624 allocated from the
valuation of the warrants issued. The discount recorded on the note is being
amortized as interest expense through the maturity date. As of December 31,
2022, the net book value of the promissory note amounted to $500,000, including
the principal amount of $50,000 which was fully amortized.
On October 28, 2019, the Company's subsidiary CNP Operating entered into a
promissory note payable with Complete Business Solutions Group, Inc ("CBSG")
whereby the Company borrowed $3,050,000. The outstanding balance of the note was
$2,218,000 at December 31, 2022. At December 31, 2022, the Company reversed
$1,312,080 previously recorded to additional paid-in capital in 2022 to reflect
the outstanding principal of $2,218,000. The note is currently in default and
personally guaranteed by Anthony Zingarelli.
On September 30, 2019, the Company's subsidiary CNP Operating entered into a
promissory note payable with Eagle Six Consultants, Inc. ("Eagle") whereby the
Company borrowed $550,000 bearing interest at 16% per annum. The outstanding
balance of the note was $302,489 at December 31, 2022. The note is currently in
default.
On May 6, 2020, the Company entered into a promissory note, or the Note, with
Pacific Western Bank, evidencing an unsecured loan, or the Loan, in the amount
of $263,000 made to the Company under the Paycheck Protection Program, or the
PPP. The interest rate on the Loan is 1.0% per annum. The Note matured on May 6,
2022. The Company has applied for full forgiveness of the amounts due under the
Note and received forgiveness during the year ended 2021.
On June 24, 2020, the Company entered into a Loan Authorization and Agreement
with the SBA under which the Company borrowed $150,000 and issued to the SBA a
note and security agreement for the amount borrowed. Outstanding borrowings
accrue interest at a rate of 3.75% per annum, and installment payments,
including principal and interest, of $731 are due monthly and begin 12 months
from the date of the loan agreement. The balance of any remaining principal and
interest is due 30 years from the date of the loan agreement. As collateral for
the borrowing, the Company granted the SBA a security interest in substantially
all assets of the Company.
On February 25, 2021, the Company entered into a secondary promissory note, or
the Second PPP Note, with Pacific Western Bank, evidencing an unsecured loan, or
the Second Loan, in the amount of $263,000 made to the Company under the PPP.
The interest rate on the Loan is 1.0% per annum. The Note matures on May 6,
2022. The Company applied for full forgiveness of the amounts due under the Note
and received forgiveness in February 2022 therefore the company has recorded the
forgiveness as of December 31, 2021.
On May 12, 2021, the Company's subsidiary CNP Operating restructured the CSBG
note payable of $2,957,000, the Eagle #1 note payable of $550,000 and the Eagle
#2 note payable of $300,000 by entering into a payment and indemnification
agreement with the receivers/trustee of CBSG and Eagle. The receiver has agreed
that the balance of the outstanding amounts will be paid over the course of 24
months in equal payments of $158,625. Further, the Company shall pay $20,000 per
month toward the balance and Anthony Zingarelli ("Zingarelli") and Colorado Sky
Industrial Supply LLC ("CSIS"), agree to personally pay the sum of $138,625 per
month. Zingarelli is the only member of CNP Operating that signed a personal
guarantee on the loans and Zingarelli is the sole member of CSIS. Zingarelli and
CSIS has agreed to indemnify and hold the Company harmless from any and all
losses, liabilities and claims. If a loss is incurred by the Company with
respect to any claims, Zingarelli shall reimburse the Company for
--------------------------------------------------------------------------------
21
--------------------------------------------------------------------------------
the amount of any such loss. The Company has recorded the Zingarelli payments
during the period as contributions to additional paid in capital through
December 31, 2021. This note is currently in default.
On November 19, 2020, the Company's subsidiary CNP Operating purchased equipment
for $58,095 which was financed at zero interest rate. The monthly payments of
$968 will be made for the next 60 months and mature on November 19, 2025.
Imputed interest was not material. The outstanding balance of the note was
$34,892 at December 31, 2022. In 2022, CNP purchased equipment for $55,016 which
was financed at zero interest rate with the same lender with similar terms. The
outstanding balance of the note was $48,513 at December 31, 2022, and was fully
repaid in 2023.
On October 19, 2021, the Company borrowed $250,000 from a lender and issued a
promissory note for the repayment of the amount borrowed. The promissory note is
unsecured, has a maturity date of December 31, 2024 and all principal is due
upon maturity. The amount borrowed accrues interest at 12% per annum and accrued
interest is payable monthly commencing on December 1, 2021. The promissory note
contains customary events of default permitting acceleration of repayment for
nonpayment of amounts due, a bankruptcy related proceeding, breach of
representations or covenants, sale of substantially all assets, and change of
control.
On April 8, 2022, the Company entered into two promissory notes for aggregate
proceeds of $676,000. The promissory note is unsecured, has a maturity date of
April 30, 2024 and all principal is due upon maturity. The notes bear interest
at 18% per annum and accrued interest is payable monthly commencing on August 1,
2022. In connection with the notes, the Company granted 676,000 warrants to the
lenders with an exercise price of $1.00 per share. The warrants were valued
using the Black-Scholes model and determined a fair value of $302,537, which was
recorded as a debt discount and will be amortized to interest expense over the
life of the notes.
On October 4, 2022, the Company converted the entire $676,000 in principal and
$50,700 in accrued interest on its convertible notes into an aggregate of
2,906,800 shares of common stock. As a result of the conversion, the Company
recorded a loss on conversion of $571,220. During the year ended December 31,
2022, the Company fully amortized the $302,537 debt discount.
On May 11, 2022, the Company's subsidiary, CFN Real Estate II, LLC, entered
into a promissory note with a lender for the repayment of $500,000 in connection
with the $500,000 refinancing of the Company's property located in Wray,
Colorado. The company received the proceeds from the refinancing on May 16,
2022. Accrued interest at the rate of 12% is payable monthly commencing on June
15, 2022, and the principal of the promissory note is payable upon maturity on
June 15, 2024. The lender received a security interest in the property and
equipment contained therein as collateral for the promissory note. The
promissory note contains customary events of default and other conditions.
Future scheduled maturities of long-term debt are as follows.
December 31,
2022
2023 $ 3,088,250
2024 793,585
2025 43,585
2026 27,263
2027 12,507
Thereafter 101,396
4,066,587
The aggregate current portion of long-term debt as of December 31, 2022 amounted
is $3,088,250, which represents the contractual principal payments due in the
next 12 months period as well as any notes in default.
--------------------------------------------------------------------------------
22
--------------------------------------------------------------------------------
Obligations Under Preferred Stock
On June 20, 2019, existing debtholders were issued an aggregate of 500 shares of
Series A Preferred Stock, each with a stated value per share of $1,000, as
conversion of $500,000 worth of outstanding promissory notes. The Series A
Preferred Stock bears interest at 12% per annum, and is convertible into our
common stock at the election of the holder at a conversion price per share to be
mutually agreed between us and the holder in the future, and be redeemable at
our option following the third year after issuance, without voting rights or a
liquidation preference.
On June 20, 2019, we issued 3,000 shares of Series B Preferred Stock, each with
a stated value of $1,000 per share, to Emerging Growth, LLC as part of the
Emerging Growth Agreement. The aggregate fair value of $687,000 was recorded as
part of the acquisition price of the net assets acquired from Emerging Growth,
LLC. The Series B Preferred Stock bears interest at 6% per annum and is
convertible into our common stock at the election of Emerging Growth, LLC at a
conversion price per share to be mutually agreed between us and Emerging Growth,
LLC in the future, without voting rights or a liquidation preference, except
with respect to accrued penalty interest.
Other outstanding obligations at December 31, 2022
Warrants
As of December 31, 2022, 988,500 shares of our common stock are issuable
pursuant to the exercise of warrants.
Options
As of December 31, 2022, no shares of our common stock are issuable pursuant to
the exercise of options.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
COVID-19
In March 2020, the outbreak of COVID-19 caused by a novel strain of the
coronavirus was recognized as a pandemic by the World Health Organization, and
the outbreak has become increasingly widespread in the United States, including
each of the areas in which we operate. While to date we have not been required
to stop operating, COVID-19 has had and is expected to continue to have an
adverse effect on the financial condition of us and our customers. The outbreak
of COVID-19 in the U.S. has had an unfavorable impact on our business
operations. Our main customer market suffered its worst decline, decreasing our
revenue. Mandatory closures of businesses imposed by the federal, state and
local governments to control the spread of the virus is disrupting the
operations of our management, business and finance teams. In addition, the
COVID-19 outbreak has adversely affected the U.S. economy and financial markets,
which may result in a long-term economic downturn that could negatively affect
future performance. We took steps to diversify our revenue model by creating our
CBD ecommerce business which has higher margins during the second half of 2020
and reduce our costs. The extent to which COVID-19 will impact our business and
our consolidated financial results further will depend on future developments
which are highly uncertain and cannot be predicted at this time, but may result
in a material adverse impact on our business, results of operations and
financial condition.
Climate Change
Our opinion is that neither climate change, nor governmental regulations related
to climate change, have had, or are expected to have, any material effect on our
operations.
--------------------------------------------------------------------------------
23
--------------------------------------------------------------------------------
Critical Accounting Policies
Accounts Receivable
The Company's account receivables are due from sales billed to customers. The
Company also maintains allowances for doubtful accounts for estimated losses
resulting from the inability of the Company's customers to make payments. The
Company periodically reviews these estimated allowances, including an analysis
of the customers' payment history and creditworthiness, the age of the trade
receivable balances and current economic conditions that may affect a customer's
ability to make payments as well as historical collection trends for its
customers as a whole. Based on this review, the Company specifically reserves
for those accounts deemed uncollectible or likely to become uncollectible. When
receivables are determined to be uncollectible, principal amounts of such
receivables outstanding are deducted from the allowance.
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards
Codification, or ASC, 606, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to
customers in an amount that reflects the consideration to which the entity
expects to be entitled to receive in exchange for those goods or services. To
achieve this core principle, five basic criteria must be met before revenue can
be recognized: (1) identify the contract with a customer; (2) identify the
performance obligations in the contract; (3) determine the transaction price;
(4) allocate the transaction price to performance obligations in the contract;
and (5) recognize revenue when or as the Company satisfies a performance
obligation.
Subsequent to the closing of the Emerging Growth Agreement on June 20, 2019, the
Company's revenue is generated from the sale of promotional service packages to
its customers ranging from 3 to 6 months. The Company offers different packages
tailored to the type and stage of the potential customer, such as public
companies looking to increase their shareholder base, as well as private
companies potentially looking to go public and attract capital and publicity.
The services provided by the Company include advertising, publishing of
interviews and articles across its network and featuring of client content on
its newsletters and social media. The packages all have fixed prices that are
billed monthly over the terms of the agreement in even amounts. The Company
recognizes revenue for its performance obligation associated with its contracts
with customers over time as work is performed, which is deemed to occur evenly
throughout the duration of the contract. This also reflects the pattern in which
costs are incurred on performing the contracts. To the extent revenue recognized
on contracts at each period end exceeds collections, the amounts are reflected
as accounts receivable. To the extent collections on contracts at each period
end exceeds revenue recognized, the amounts are reflected as deferred revenue.
Income Taxes
Income taxes are accounted for in accordance with the provisions of ASC Topic
740, Accounting for Income Taxes. Deferred tax assets and liabilities are
recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or settled. The
effect on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the
amounts expected to be realized, but no less than quarterly.
Property and Equipment
Property and equipment are recorded at cost and are depreciated on a
straight-line basis over their estimated useful lives of five years. Maintenance
and repairs are charged to expense as incurred. Significant renewals and
betterments are capitalized.
--------------------------------------------------------------------------------
24
--------------------------------------------------------------------------------
Goodwill
The Company's goodwill represents the excess of purchase price over tangible and
intangible assets acquired, less liabilities assumed arising from business
acquisitions. Goodwill is not amortized, but is reviewed for potential
impairment on an annual basis at the reporting unit level.
Long-Lived Assets
In accordance with ASC 360-10, the Company evaluates long-lived assets for
impairment whenever events or changes in circumstances indicate that their net
book value may not be recoverable. When such factors and circumstances exist,
the Company compares the projected undiscounted future cash flows associated
with the related asset or group of assets over their estimated useful lives
against their respective carrying amount. Impairment, if any, is based on the
excess of the carrying amount over the fair value, based on market value when
available, or discounted expected cash flows, of those assets and is recorded in
the period in which the determination is made.
Basic and Diluted Earnings Per Share
Basic earnings per share are calculated by dividing income available to
stockholders by the weighted-average number of common shares outstanding during
each period. Diluted earnings per share are computed using the weighted average
number of common and dilutive common share equivalents outstanding during the
period. Dilutive common share equivalents consist of shares issuable upon the
exercise of stock options, warrants and preferred stock (calculated using the
modified-treasury stock method.
Share-Based Payment
The Company accounts for stock-based compensation in accordance with ASC Topic
718, Compensation-Stock Compensation, or ASC 718. Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured
at the grant date based on the fair value of the award and is recognized as an
expense on a straight-line basis over the requisite service period, which is the
vesting period.
The Company has elected to use the Black-Scholes option-pricing model to
estimate the fair value of its options, which incorporates various subjective
assumptions including volatility, risk-free interest rate, expected life, and
dividend yield to calculate the fair value of stock option awards. Compensation
expense recognized in the statements of operations is based on awards ultimately
expected to vest and reflects estimated forfeitures. ASC 718 requires
forfeitures to be estimated at the time of grant and revised, if necessary, in
subsequent periods if actual forfeitures differ from those estimates.
Common stock awards
The Company has granted common stock awards to non-employees in exchange for
services provided. The Company measures the fair value of these awards using the
fair value of the services provided or the fair value of the awards granted. The
fair value of the awards is recognized on a straight-line basis as services are
rendered. The share-based payments related to common stock awards for the
settlement of services provided by non-employees is recorded on the consolidated
statement of comprehensive loss in the same manner and charged to the same
account as if such settlements had been made in cash.
Warrants
In connection with certain financing, consulting and collaboration arrangements,
the Company has issued warrants to purchase shares of its common stock. The
outstanding warrants are standalone instruments that are not puttable or
mandatorily redeemable by the holder and are classified as equity awards. The
Company measures the fair value of the awards using the Black-Scholes option
pricing model as of the measurement date. Warrants are recorded at fair value as
expense over the requisite service period or at the date of issuance, if there
is not a service period.
--------------------------------------------------------------------------------
25
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses